These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34328655)

  • 41. PSICA: Decision trees for probabilistic subgroup identification with categorical treatments.
    Sysoev O; Bartoszek K; Ekström EC; Ekholm Selling K
    Stat Med; 2019 Sep; 38(22):4436-4452. PubMed ID: 31246349
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic biomarkers to identify patients likely to develop severe Crohn's disease: a systematic review.
    Halligan S; Boone D; Archer L; Ahmad T; Bloom S; Rodriguez-Justo M; Taylor SA; Mallett S
    Health Technol Assess; 2021 Jul; 25(45):1-66. PubMed ID: 34225839
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictive biomarkers for treatment selection: statistical considerations.
    Chen JJ; Lu TP; Chen YC; Lin WJ
    Biomark Med; 2015; 9(11):1121-35. PubMed ID: 26507127
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A nonparametric method for value function guided subgroup identification via gradient tree boosting for censored survival data.
    Zhang P; Ma J; Chen X; Shentu Y
    Stat Med; 2020 Dec; 39(28):4133-4146. PubMed ID: 32786155
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Strategies for identifying predictive biomarkers and subgroups with enhanced treatment effect in clinical trials using SIDES.
    Lipkovich I; Dmitrienko A
    J Biopharm Stat; 2014; 24(1):130-53. PubMed ID: 24392982
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Searching for robust associations with a multi-environment knockoff filter.
    Li S; Sesia M; Romano Y; Candès E; Sabatti C
    Biometrika; 2022 Sep; 109(3):611-629. PubMed ID: 38633763
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of acromegaly in the era of personalized and predictive medicine.
    Puig Domingo M
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):3-14. PubMed ID: 25640882
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Change plane model averaging for subgroup identification.
    Liu P; Li J; Kosorok MR
    Stat Methods Med Res; 2023 Apr; 32(4):773-788. PubMed ID: 36775991
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Precision medicine: Subgroup identification in longitudinal trajectories.
    Wei Y; Liu L; Su X; Zhao L; Jiang H
    Stat Methods Med Res; 2020 Sep; 29(9):2603-2616. PubMed ID: 32070237
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Why have so few proteomic biomarkers "survived" validation? (Sample size and independent validation considerations).
    Hernández B; Parnell A; Pennington SR
    Proteomics; 2014 Jul; 14(13-14):1587-92. PubMed ID: 24737731
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictive biomarkers for personalised anti-cancer drug use: discovery to clinical implementation.
    Alymani NA; Smith MD; Williams DJ; Petty RD
    Eur J Cancer; 2010 Mar; 46(5):869-79. PubMed ID: 20138504
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A random forest based biomarker discovery and power analysis framework for diagnostics research.
    Acharjee A; Larkman J; Xu Y; Cardoso VR; Gkoutos GV
    BMC Med Genomics; 2020 Nov; 13(1):178. PubMed ID: 33228632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ASIED: a Bayesian adaptive subgroup-identification enrichment design.
    Xu Y; Constantine F; Yuan Y; Pritchett YL
    J Biopharm Stat; 2020 Jul; 30(4):623-638. PubMed ID: 31782938
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Grace-AKO: a novel and stable knockoff filter for variable selection incorporating gene network structures.
    Tian P; Hu Y; Liu Z; Zhang YD
    BMC Bioinformatics; 2022 Nov; 23(1):478. PubMed ID: 36376815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NCC-AUC: an AUC optimization method to identify multi-biomarker panel for cancer prognosis from genomic and clinical data.
    Zou M; Liu Z; Zhang XS; Wang Y
    Bioinformatics; 2015 Oct; 31(20):3330-8. PubMed ID: 26092859
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Subtype classification and heterogeneous prognosis model construction in precision medicine.
    You N; He S; Wang X; Zhu J; Zhang H
    Biometrics; 2018 Sep; 74(3):814-822. PubMed ID: 29359319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Performance of variable selection methods using stability-based selection.
    Lu D; Weljie A; de Leon AR; McConnell Y; Bathe OF; Kopciuk K
    BMC Res Notes; 2017 Apr; 10(1):143. PubMed ID: 28376847
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biomarker discovery in inflammatory bowel diseases using network-based feature selection.
    Abbas M; Matta J; Le T; Bensmail H; Obafemi-Ajayi T; Honavar V; El-Manzalawy Y
    PLoS One; 2019; 14(11):e0225382. PubMed ID: 31756219
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Personalized medicine using DNA biomarkers: a review.
    Ziegler A; Koch A; Krockenberger K; Grosshennig A
    Hum Genet; 2012 Oct; 131(10):1627-38. PubMed ID: 22752797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.